Adenocarcinoma of the Pancreas Completed Phase 2 Trials for Tanespimycin (DB05134)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00577889Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic CancerTreatment